SCHEMBL5445830

SCHEMBL5445830

CNC(=O)COC(=O)N1CCC(O)(c2ccc(-c3ccc(F)c(Cl)c3)cc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.46
S1PR2 O95136 2/20 0.41
MCHR1 Q99705 5/20 0.40
DRD4 P21917 2/20 0.39
DRD2 P14416 2/20 0.39
KDM4E B2RXH2 1/20 0.39
DRD3 P35462 1/20 0.39
ENPP2 Q13822 1/20 0.39
ATXN2 Q99700 1/20 0.39
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
HRH2 P25021 1/20 0.38
SLC6A4 P31645 1/20 0.38
ADRA1A P35348 1/20 0.38
HRH1 P35367 1/20 0.38
OPRM1 P35372 1/20 0.38
KCNH2 Q12809 1/20 0.38
SCN5A Q14524 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5443508 0.91 FAAH (0.46) FAAHS1PR2DRD4KDM4EADRA2A
SCHEMBL5442739 0.89 FAAH (0.57) FAAHS1PR2DRD4DRD2KDM4E
SCHEMBL5453462 0.87 SMN1; SMN2 (0.46) FAAHS1PR2DRD4DRD2DRD3
SCHEMBL5445795 0.85 KDM4E (0.42) FAAHMCHR1KDM4EALDH1A1
SCHEMBL5445764 0.83 FAAH (0.45) FAAHDRD2OPRM1ALDH1A1SMN1; SMN2
SCHEMBL5447955 0.82 FAAH (0.44) FAAHS1PR2DRD4DRD2ENPP2
SCHEMBL5447927 0.81 SMN1; SMN2 (0.45) FAAHKDM4EHRH2HRH1OPRM1
SCHEMBL5452097 0.80 GAA (0.46) FAAHKDM4EHRH2HRH1HRH3
SCHEMBL5442748 0.79 FAAH (0.47) FAAHS1PR2DRD2DRD3ADRA2A
SCHEMBL1581501 0.79 DRD2 (0.45) S1PR2MCHR1DRD4DRD2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070021405-A1 ARYL- AND HETEROARYLPIPERIDINECARBOXYLATE-DERIVATIVES METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS SANOFI-AVENTIS (FR) 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021405-A1 ARYL- AND HETEROARYLPIPERIDINECARBOXYLATE-DERIVATIVES METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS FAAH, FAAH2, HRH2 FAAH 1/4885S1PR2 970/4885MCHR1 1637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.